Engineers Gate Manager’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,075
Closed -$94.8K 2213
2023
Q4
$94.8K Buy
+19,075
New +$94.8K ﹤0.01% 1785
2022
Q1
Sell
-17,444
Closed -$141K 2207
2021
Q4
$141K Buy
17,444
+4,130
+31% +$44.4K 0.01% 1745
2021
Q3
$198K Buy
+13,314
New +$166K 0.01% 1440

Other funds holding PDSB

Engineers Gate Manager's PDSB Position: Q1 2024 in Review

Engineers Gate Manager sold out of PDS Biotechnology (PDSB) in Q1 2024, closing a stake of 19,075 shares — an estimated $94.8K sold.

Engineers Gate Manager first reported a position in PDSB in Q3 2021 and held it in 3 quarters. The position peaked at $198K in Q3 2021. 72 funds tracked by Wall St. Rank hold PDSB as of Q1 2024.

  • Engineers Gate Manager reported no remaining PDS Biotechnology position as of Q1 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 19,075 PDS Biotechnology shares in Q1 2024, an estimated $94.8K.
  • Engineers Gate Manager first reported a position in PDS Biotechnology in Q3 2021 and held it in 3 quarters.
  • Engineers Gate Manager's PDS Biotechnology position peaked at $198K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2024.

Based on Engineers Gate Manager's 13F filing for Q1 2024, filed 15 May 2024.